Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Tests acupuncture for quality of life in people with primary headaches

Tests real versus sham acupuncture in adults with primary headaches.

Plain-language title generated from the registry record
Registry title: Investigating the Impact of Acupuncture on the Quality of Life of Primitive Headaches Patients

Key facts

Where
Taoyuan, TaiwanSee the site

Where in Taiwan

  • Chang Gung Memorial HospitalTaoyuan, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chang Gung Memorial Hospital
Trial code
NCT06398353
Record updated
7 May 2024
Original description
Primary headache is one of the most common neurological diseases in modern society, which seriously affects the patient's quality of life. Although the use of painkillers can alleviate primary headache symptoms, it may also cause drug dependence. Therefore, alternative therapies that do not rely on drugs have attracted increasing attention in recent years. Among them, acupuncture has been partially recognized by the public as an effective treatment for primary headaches. However, there is currently no scientific evidence that acupuncture is effective for primary headaches. The purpose of this project is to verify the effect of acupuncture in treating primary headaches. This study has three sub-projects:Read full original descriptionShow less

Investigating the Impact of Acupuncture on the Quality of Life of Primitive Headaches Patients

Primary headache is one of the most common neurological diseases in modern society, which seriously affects the patient's quality of life. Although the use of painkillers can alleviate primary headache symptoms, it may also cause drug dependence. Therefore, alternative therapies that do not rely on drugs have attracted increasing attention in recent years. Among them, acupuncture has been partially recognized by the public as an effective treatment for primary headaches. However, there is currently no scientific evidence that acupuncture is effective for primary headaches. The purpose of this project is to verify the effect of acupuncture in treating primary headaches. This study has three sub-projects:

Subproject 2 explores the impact of acupuncture on headache severity and quality of life in patients with primary headaches. We evaluate the quality of life before and after acupuncture treatment through professional questionnaires, including the Numerical rating scale (NRS), headache diary, depression, anxiety and stress scale (DASS-21), health quality of life measurement questionnaire, Migraine Disability Assessment Scale and SF-36 Taiwan version. Finally, these data will be combined with the pulseway analysis from the results of sub-project 1 to provide a comprehensive way to evaluate the treatment effect.

Inclusion: Willing to sign a written subject consent form; Male or female over 18 years old; Those who have headaches (for example: dizziness, heavy head, dizziness, head fullness, migraine), those who have headaches more than twice a week, and whose NRS score is ˃ 4; Headache definition: Headache symptoms are classified according to the ICHD-3 headache classification of the International Headache Organization, and are mainly primary headaches; Dr. Chang ,Y.-J. and Dr. Yang ,C.-C. help to exclude headache patients with the following exclusion conditions to reduce the risk to subjects; Exclusin Criteria; Pregnant women; Various acute and chronic infectious diseases, various skin ulcers, sores, burns, etc; The patient has injuries to the radial artery or wrist, or has steel nails, plates, or fractures; Various types of headaches related to anatomical structural lesions; Headaches associated with taking or withdrawing from substances (drugs, food, or other chemicals); Headaches related to non-head infections and metabolic diseases; People with painful cranial neuropathy, other facial pain and other headaches; People with secondary headaches according to ICHD-3 beta; Other patients who have been evaluated by physicians as not suitable for inclusion in the evaluation.

ClinicalTrials.gov NCT06398353